Big Weekly Winners: Swing Trading with PowerRatings

PowerRatings provides traders with the optimal information they need to place successful trades over a 3-5 trading day period. Over this last trading week, the top-performing stocks and exchange traded funds came from the healthcare sector and biotechnology industry.

The stocks and ETFs in this week’s Big Weekly Winners: Swing Trading with PowerRatings all earned PowerRatings of 8 or higher one week ago on May 4th, 2012.

To learn more about PowerRatings, including how to swing trade stocks and ETFs with PowerRatings, click here.

Performance of 5/4/12 – 5/11/12 Trading Week

Achillion Pharmaceuticals, Inc. (ACHN)

ACHN chart

After an upgrade by UBS earlier in the week on May 7th, a strong first-quarter revenue report on May 9th, and news of a new drug application with the FDA, shares of Achillion Pharmaceuticals Inc. rose for a 20.20% gain for the week.

  • 5/4/12 Entry Price: 5.99 with a PowerRating of 8
  • 5/11/12 Exit Price: 7.20
  • Gain: 20.20%

Anika Therapeutics Inc. (ANIK)

ANIK chart

A frontrunner in the production of human tissue protection products, Anika Therapeutics Inc. saw its shares gain a little over 9% this week after positive sales reports of its principal products and a reported 22% total revenue growth in its first-quarter results.

  • 5/4/12 Entry Price: 13.79 with a PowerRating of 9
  • 5/11/12 Exit Price: 15.04
  • Gain: 9.06%

SPDR S&P Biotech (XBI)

XBI chart

Biotechnology ETFs saw a bump this week with several companies reporting promising results of recent studies. The SPDR S&P Biotech ETF gained 4.79% after pulling back slightly in volume from a high earlier in the month.

  • 5/4/12 Entry Price: 78.80 with a PowerRating of 9
  • 5/11/12 Exit Price: 82.58
  • Gain: 4.79%

Learn how to swing trade using PowerRatings! Click here to launch your free trial to PowerRatings today. Free trials include full access to our entire database of stocks, ETFs and leveraged ETFs, as well as swing trader training videos.

Joshua Glasgall is Editor in Chief of Connors Research